Jesper Høiland
Director/Board Member at ALK-ABELLÓ A/S
Jesper Høiland active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ALK-ABELLÓ A/S | Director/Board Member | - | - |
| Novo Nordisk North America, Inc. | Corporate Officer/Principal | 2012-12-31 | - |
Career history of Jesper Høiland
Former positions of Jesper Høiland
| Companies | Position | Start | End |
|---|---|---|---|
| ASCENDIS PHARMA A/S | Corporate Officer/Principal | 2020-05-10 | 2022-05-22 |
| RADIUS HEALTH, INC. | Director/Board Member | 2017-07-16 | 2020-04-27 |
| Chief Executive Officer | 2017-07-16 | 2020-04-27 | |
| President | 2017-07-16 | 2020-04-27 | |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | President | 2012-12-31 | 2017-02-28 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Director/Board Member | 2013-12-31 | 2015-12-31 |
| NOVO NORDISK A/S | Corporate Officer/Principal | 2011-01-24 | 2011-12-31 |
| Liseberg AB | Corporate Officer/Principal | 1984-12-31 | 1986-12-31 |
| CONCERT PHARMACEUTICALS, INC. | Director/Board Member | 2019-04-28 | - |
| Independent Dir/Board Member | 2019-04-28 | - | |
| ░░░ ░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░ ░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Training of Jesper Høiland
| Copenhagen Business School | Graduate Degree |
Statistics
International
| Denmark | 6 |
| United States | 6 |
| Sweden | 2 |
Operational
| Corporate Officer/Principal | 5 |
| Director/Board Member | 5 |
| President | 2 |
Sectoral
| Health Technology | 10 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| ASCENDIS PHARMA A/S | Health Technology |
| ALK-ABELLÓ A/S | Health Technology |
| Private companies | 8 |
|---|---|
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
| Liseberg AB | |
Novo Nordisk Pharmaceuticals Pty Ltd.
 Novo Nordisk Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Novo Nordisk Pharmaceuticals Pty Ltd. manufactures pharmaceuticals for diabetes care. The company is headquartered in Baulkham Hills, Australia. | Health Technology |
| Novo Nordisk North America, Inc. | |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Health Technology |
Radius Health, Inc.
 Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Concert Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which discovers and develops novel small molecule drugs through the use of deuterium technology. Its product candidates target a range of diseases including autoimmune disorders, inflammation, and central nervous system disorders. The company was founded by Richard H. Aldrich, Roger D. Tung and Christoph H. Westphal on April 12, 2006 and is headquartered in Lexington, MA. | Health Technology |
- Stock Market
- Insiders
- Jesper Høiland
- Experience
